News Focus
News Focus
icon url

reg2015

09/22/18 11:09 AM

#190864 RE: longfellow95 #190858

longfellow95 and Lykin, WOW. That is for me, very impressive information. The direct connection between product and manufacturing by the highest regarded scientist. A member of NWBO consultant? Ms. Powers truly travels in emanate circles. What an interesting Sat. this is turning out to be. Thank you to all who are posting here and debating the tons of subjects that keep everyone digging and throwing around facts and opinions and, yes, my emotional dribble. I do hope someday to see and in-deapth book on the entire story. From Ms. Powers buying up a failing, but promising company, to where ever this story leads to.

JMHO, Monday morning quarterbacking is something I am prone to, but not proud of. My J e t s, make me ashamed of myself because I always ask, "Why did they do that dumb thing?" LOL. So, we are saying the same thing about Ms. Powers and how this situation has evolved over many years and we, long shareholders, still have some value on our accounts, although not as much as when we first began.

I just hope and pray she makes it to the "finish line" and we all get to see whatever results are finally published. "staying tuned". Peace Reg2015
icon url

longfellow95

09/22/18 11:44 AM

#190875 RE: longfellow95 #190858

Professor Lowdell has held and holds numerous appointments to academic and government advisory boards in the UK and overseas. Recently he was a member of the UK Government Regenerative Medicine Expert Review Group and is a member of the scientific advisory boards, consultant to or founder of many of the key companies involved in ATMP development in the EU and USA including Autolus Ltd, Achilles Therapeutics Ltd, Cell Medica Ltd, InmuneBio Inc, Novamune Ltd and NWBio Therapeutics.



https://www.terrapinn.com/conference/festival-of-biologics-usa/speaker-mark-LOWDELL.stm